Please use this form to send any questions, bug reports, or suggestions. If you are reporting a bug, please include detailed information about what you were doing, and attach any relevant screenshots, if possible.
Thank you for providing your feedback! Someone will be in touch with you shortly. This window will automatically close in 5 seconds.
Erythromycin is a macrolide antibiotic produced by Saccharopolyspora erythraea (formerly Streptomyces erythraeus). It inhibits bacterial protein synthesis by binding to bacterial 50S ribosomal subunits; binding inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Erythromycin may be bacteriostatic or bactericidal depending on the organism and drug concentration.
Erythromycin Ethylsuccinate and Sulfisoxazole Acetyl
Erythromycin Ophthalmic Ointment U.S.P.
Erythromycin Ophthalmic Ointment USP
Erythromycin Stearate Tablets USP 250mg
Erythromycin and Benzoyl Peroxide
Erythromycine 250 Tab
Ilosone 250mg Pulvule 375
Ilosone Liquid 125mg/5ml
Ilosone Liquid 250mg/5ml
Ilotycin Cryst Op Ont 0.5% 52
Ilotycin Gluceptate IV Ampoule 646 1gm
Novo-rythro Encap 250mg
Novo-rythro Estolate Cap 250mg
Novo-rythro Estolate Suspension
Novo-rythro Ethylsuccinate Pwr 400mg/5ml
Novo-rythro Ethylsuccinate Pws
Novo-rythro Stearate Tab 250mg
Nu-erythromycin-S 250mg Tablets
Onguent Ophtalmique D'erythromycine USP
Sterile Erythromycin Lactobionate Pws 1000mg
Sterile Erythromycin Lactobionate Pws 500mg
Enteric bacteria and other eubacteria
For use in the treatment of infections caused by susceptible strains of microorganisms in the following diseases: respiratory tract infections (upper and lower) of mild to moderate degree, pertussis (whooping cough), as adjunct to antitoxin in infections due to <i>Corynebacterium diphtheriae</i>, in the treatment of infections due to <i>Corynebacterium minutissimum</i>, intestinal amebiasis caused by <i>Entamoeba histolytica</i>, acute pelvic inflammatory disease caused by <i>Neisseria gonorrhoeae</i>, skin and soft tissue infections of mild to moderate severity caused by <i>Streptococcus pyogenes</i> and <i>Staphylococcus aureus</i>, primary syphilis caused by <i>Treponema pallidum</i>, infections caused by <i>Chlamydia trachomatis</i>, nongonococcal urethritis caused by <i>Ureaplasma urealyticum</i>, and Legionnaires' disease caused by <i>Legionella pneumophila</i>.
Erythromycin is produced by a strain of Streptomyces erythraeus and belongs to the macrolide group of antibiotics. After absorption, erythromycin diffuses readily into most body fluids. In the absence of meningeal inflammation, low concentrations are normally achieved in the spinal fluid, but the passage of the drug across the blood-brain barrier increases in meningitis. Erythromycin is excreted in breast milk. The drug crosses the placental barrier with fetal serum drug levels reaching 5 - 20% of maternal serum concentrations. Erythromycin is not removed by peritoneal dialysis or hemodialysis.
Mechanism of action
Erythromycin acts by penetrating the bacterial cell membrane and reversibly binding to the 50 S subunit of bacterial ribosomes or near the “P” or donor site so that binding of tRNA (transfer RNA) to the donor site is blocked. Translocation of peptides from the “A” or acceptor site to the “P” or donor site is prevented, and subsequent protein synthesis is inhibited. Erythromycin is effective only against actively dividing organisms. The exact mechanism by which erythmromycin reduces lesions of acne vulgaris is not fully known: however, the effect appears to be due in part to the antibacterial activity of the drug.
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682